NCT00708552 - Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease | Biotech Hunter

Enrollment

576

Participants

Timeline

Start Date

July 4, 2008

Primary Completion Date

March 1, 2010

Study Completion Date

March 9, 2010

Conditions

Alzheimer's Disease

Interventions

DRUG

SB-742457

investigational drug

DRUG

Donepezil

comparator

DRUG

Placebo

comparator

Trial Locations (72)

1113

GSK Investigational Site, Sofia

1431

GSK Investigational Site, Sofia

2157

GSK Investigational Site, Sunninghill

2196

GSK Investigational Site, Rosebank

4001

GSK Investigational Site, Durban

7530

GSK Investigational Site, Loeventstein

GSK Investigational Site, Oakdale

9010

GSK Investigational Site, Varna

9700

GSK Investigational Site, Shumen

10000

GSK Investigational Site, Prague

10138

GSK Investigational Site, Tallinn

10617

GSK Investigational Site, Tallinn

11528

GSK Investigational Site, Athens

14050

GSK Investigational Site, Mexico City

20127

GSK Investigational Site, Aguascalientes, Ags

20249

GSK Investigational Site, Hamburg

22320

GSK Investigational Site, Tijuana

25000

GSK Investigational Site, Saltillo

28832

GSK Investigational Site, Achim

30559

GSK Investigational Site, Hanover

35625

GSK Investigational Site, Hüttenberg

44805

GSK Investigational Site, Bochum

44892

GSK Investigational Site, Bochum

45525

GSK Investigational Site, Hattingen

47051

GSK Investigational Site, Duisburg

50935

GSK Investigational Site, Cologne

51014

GSK Investigational Site, Tartu

52349

GSK Investigational Site, Düren

57010

GSK Investigational Site, Thessaloniki

57072

GSK Investigational Site, Siegen

61348

GSK Investigational Site, Bad Homburg

64660

GSK Investigational Site, Monterrey

64711

GSK Investigational Site, Erbach im Odenwald

70178

GSK Investigational Site, Stuttgart

72076

GSK Investigational Site, Tübingen

80331

GSK Investigational Site, Munich

81675

GSK Investigational Site, Munich

82008

GSK Investigational Site, Unterhaching

86633

GSK Investigational Site, Neuburg an der Donau

90402

GSK Investigational Site, Nuremberg

115522

GSK Investigational Site, Moscow

115552

GSK Investigational Site, Moscow

117049

GSK Investigational Site, Moscow

198103

GSK Investigational Site, Saint Petersburg

7510186

GSK Investigational Site, Santiago

7560356

GSK Investigational Site, Santiago

252-0997

GSK Investigational Site, Viña del Mar

Unknown

GSK Investigational Site, Santiago

GSK Investigational Site, Athens

656 91

GSK Investigational Site, Brno

775 20

GSK Investigational Site, Olomouc

100 00

GSK Investigational Site, Prague

110 00

GSK Investigational Site, Prague

120 00

GSK Investigational Site, Prague

01097

GSK Investigational Site, Dresden

04107

GSK Investigational Site, Leipzig

04157

GSK Investigational Site, Leipzig

115 21

GSK Investigational Site, Athens

151 27

GSK Investigational Site, Melíssia

06700

GSK Investigational Site, Mexico City

85-094

GSK Investigational Site, Bydgoszcz

85-796

GSK Investigational Site, Bydgoszcz

62-050

GSK Investigational Site, Mosina

61-298

GSK Investigational Site, Poznan

81-824

GSK Investigational Site, Sopot

02-097

GSK Investigational Site, Warsaw

0181

GSK Investigational Site, Pretoria

602-715

GSK Investigational Site, Busan

133-792

GSK Investigational Site, Seoul

135-710

GSK Investigational Site, Seoul

138-736

GSK Investigational Site, Seoul

158-710

GSK Investigational Site, Seoul